Startups channel feed

MPM backs new biotech in the hunt for non-opi­oid painkiller

6 years ago
Financing

Fresh from a Pfiz­er buy­out, Lu­ca Santarel­li’s crew has cre­at­ed a new com­pa­ny — bank­ing new funds and steer­ing their lead drug to a piv­otal

6 years ago
Financing

Bank­ing on Shang­hai's biotech boom, this Eli Lil­ly-backed play­er grabs $100M to push next-gen I/O ther­a­pies

6 years ago
Financing
China

Flag­ship bankrolls quest to cre­ate gene ther­a­py 2.0, with new vi­ral de­liv­ery tech in hand

6 years ago
Financing
Cell/Gene Tx

Canaan backs Pathios' search for small mol­e­cule drugs that hit 'or­phan' GCPR

6 years ago
Financing

No pain, no gain: Com­pa­ny-build­ing French VC scores €250M for life sci­ences fund

6 years ago
Financing

What uni­fies Hunt­ing­ton's, spin­ocere­bel­lar atax­ia and my­oton­ic dy­s­tro­phy? Ness Berming­ham's new start­up looks to drug that

6 years ago
Financing

Parkin­son's trans­plants emerge as stem cell pi­o­neer Jeanne Lor­ing joins R&D race

6 years ago

Cel­lar­i­ty, Flag­ship's $50M bet on net­work bi­ol­o­gy, mar­ries ma­chine learn­ing and sin­gle-cell tech for drug dis­cov­ery

6 years ago

Per­cep­tive teams up with Chris Garabe­di­an to open up a new, $210M biotech fund fo­cused on A rounds

6 years ago
Financing

Jasper Ther­a­peu­tics launch­es out of Stan­ford with new ap­proach to stem cell treat­ment

6 years ago
Financing

An­ti­body strat­e­gy to aug­ment ver­sa­tile im­mune cells sparks in­vest­ment in French biotech

6 years ago
Financing

‘Break­through’ blad­der can­cer drug spin­out gets $570M to back launch of a new gene ther­a­py in the US

6 years ago
Deals
R&D

No­var­tis, Bay­er, Long­wood back ge­nomics start­up to speed search for im­munother­a­py tar­gets

6 years ago
R&D

Can­cer Re­search UK spin­off rais­es $41M+ in Se­ries B in­jec­tion

6 years ago
Financing
R&D

With eyes on a poly­mer em­pire prize, French medtech play­er seals $42M in fresh fund­ing

6 years ago

New cell ther­a­py play­er launch­es with $57M from mar­quee in­vestors to go af­ter 'de­fin­i­tive' tu­mor tar­gets

6 years ago
Financing

New UK start­up pur­sues off-the-shelf CAR-T, can­cer vac­cines through 'dark anti­gen­s'

6 years ago

Some bat­tle test­ed neu­ro­science vets are go­ing all out on ear­ly on­set de­men­tia — with a $44M launch round to build the team

6 years ago
R&D

As CRISPR hori­zons cloud, a start­up fo­cus­es on the next big thing with pow­er­house po­ten­tial — the RNA edit­ing plat­form

6 years ago

Vik Ba­jaj un­veils Fore­site's new in­cu­ba­tor, look­ing to hatch fu­ture gi­ants cross­ing tech and health­care

6 years ago

SinoMab Bio­Science, Al­pham­ab On­col­o­gy make their way to the Hong Kong Stock Ex­change

6 years ago
Financing

Neu­ro­science biotech led by for­mer Pfiz­er crew wins $17M to tar­get tox­ic tau

6 years ago
R&D

David Hung is back, launch­ing a new on­col­o­gy start­up with $275M and big am­bi­tions to make news in can­cer drug de­vel­op­ment

6 years ago
Financing
First page Previous page 54555657585960 Next page Last page
A service from the Financial Times